These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 104348)

  • 1. The effect of gamma-butyrolactone on locomotor activity in the rat.
    Davies JA
    Psychopharmacology (Berl); 1978 Dec; 60(1):67-72. PubMed ID: 104348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tolerance to the effects of baclofen and gamma-butyrolactone on locomotor activity and dopaminergic neurons in the mouse.
    Gianutsos G; Moore KE
    J Pharmacol Exp Ther; 1978 Dec; 207(3):859-69. PubMed ID: 731436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic gamma-butyrolactone (GBL) treatment: a potential model of dopamine hypoactivity.
    Nowycky MC; Roth RH
    Naunyn Schmiedebergs Arch Pharmacol; 1979 Nov; 309(3):247-54. PubMed ID: 43476
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of gamma-butyrolactone, amphetamine, and haloperidol in mice differing in sensitivity to alcohol.
    Dudek BC; Fanelli RJ
    Psychopharmacology (Berl); 1980; 68(1):89-97. PubMed ID: 6771802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of low doses of d-amphetamine on drug-induced hyperactivity in the mouse.
    Hussey JS; Vincent ND; Davies JA
    Psychopharmacology (Berl); 1983; 81(4):327-31. PubMed ID: 6228947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for down-regulation of GABA receptors following long-term gamma-butyrolactone.
    Gianutsos G; Suzdak PD
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Nov; 328(1):62-8. PubMed ID: 6096730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gamma-butyrolactone sleep: A 24-hour rhythm paralleling normal sleep in the rat and CNS amine changes.
    Speciale SG; Friedman AH
    Pharmacol Biochem Behav; 1975; 3(5):761-4. PubMed ID: 1208618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of chloral hydrate, gamma-butyrolactone, and equithesin on the efflux of dopamine and 5-hydroxytryptamine metabolites into cerebroventricular perfusates of rats.
    Nielsen JA; Moore KE
    J Neurochem; 1982 Jul; 39(1):235-8. PubMed ID: 6177832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acceleration of the biosynthesis of rat striatal dopamine by incubation and by administration of gamma-butyrolactone.
    Dyck LE; Kazakoff CW
    J Neurosci Res; 1982; 8(1):57-65. PubMed ID: 7175978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of voluntary ethanol consumption in rats by gamma-butyrolactone.
    Fadda F; Argiolas A; Melis MR; De Montis G; Gessa GL
    Life Sci; 1983 Mar; 32(13):1471-7. PubMed ID: 6339856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. gamma-butyrolactone enhances the activity of GABA in the gastric acid secretion of anesthetized rats.
    Watanabe K; Watanabe H; Goto Y; Shimizu M; Maeda-Hagiwara M
    Jpn J Pharmacol; 1983 Dec; 33(6):1163-9. PubMed ID: 6668764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential actions of dopamine agonists and antagonists on the gamma-butyrolactone-induced in mouse brain dopamine.
    Gianutsos G; Thornburg JE; Moore KE
    Psychopharmacology (Berl); 1976 Nov; 50(3):225-9. PubMed ID: 826966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. gamma-Butyrolactone effects on behavior induced by dopamine agonists.
    Ellinwood EH; Gonzalez AE; Dougherty GG
    Biol Psychiatry; 1983 Sep; 18(9):1023-32. PubMed ID: 6685535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delayed inhibition of dopamine synthesis by gamma-butyrolactone and baclofen: dopamine autoreceptor supersensitivity?
    Argiolas A; Fadda F; Melis MR; Marcou M; Porceddu ML; Gessa GL
    Eur J Pharmacol; 1982 Nov; 85(1):23-7. PubMed ID: 6818043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An investigation of the relationship between the dopaminergic and electroencephalographic effects of gamma-butyrolactone.
    Snead OC
    Neuropharmacology; 1982 Jun; 21(6):539-43. PubMed ID: 7110537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. d-Amphetamine and gamma-butyrolactone alteration of dopamine synthesis in the terminals of nigrostriatal and mesolimbic neurons. Possible role of various autoreceptor sensitivities.
    Demarest KT; Lawson-Wendling KL; Moore KE
    Biochem Pharmacol; 1983 Feb; 32(4):691-7. PubMed ID: 6403019
    [No Abstract]   [Full Text] [Related]  

  • 17. Dopaminergic neurons: reversal of effects elicited by gamma-butyrolactone by stimulation of the nigro-neostriatal pathway.
    Murrin LC; Roth RH
    Naunyn Schmiedebergs Arch Pharmacol; 1976 Oct; 295(1):15-20. PubMed ID: 12482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of benztropine on behavioral and toxic effects of cocaine: comparison with atropine and the selective dopamine uptake inhibitor 1-[2-(diphenylmethoxy)ethyl]-4-(3-phenyl-propyl)-piperazine.
    Acri JB; Siedleck BK; Witkin JM
    J Pharmacol Exp Ther; 1996 Apr; 277(1):198-206. PubMed ID: 8613919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of protriptyline and clomipramine in vitro on the uptake of 5-hydroxytryptamine and dopamine in human platelet-rich plasma.
    Trenchard A; Turner P; Pare CM; Hills M
    Psychopharmacologia; 1975 Jul; 43(1):89-93. PubMed ID: 1161997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mode of action of gamma-butyrolactone on the central cholinergic system.
    Ladinsky H; Consolo S; Zatta A; Vezzani A
    Naunyn Schmiedebergs Arch Pharmacol; 1983 Feb; 322(1):42-8. PubMed ID: 6843688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.